Page 45 - Pharma
CNS drug research: A dilemma for big pharma companies
CNS disorders rake in more than $ 80 billion a year for the pharma industry, however higher failure rates in clinical trials are forcing big companies to cut down their spend on CNS drug R&D
 "CNS drug research: A dilemma for big pharma companies")
Govt to spend Rs 1750 cr on drug regulatory system upgradation
Out of Rs 1750 crore, Rs 900 crore will be spent on strengthening central structures and Rs 850 crore will be made available to the state governments
 "Govt to spend Rs 1750 cr on drug regulatory system upgradation")
Lupin opens inhalation research centre in US
The new centre in Florida will to focus on the R&D of inhalation products for the treatment of asthma, chronic obstructive pulmonary diseases and other lung diseases
Dr Reddy's forms strategic tie up with Amgen
The company will market and distribute Amgen's Repatha (evolocumab), Kyprolis (carfilzomib) and Blincyto (blinatumomab) in India upon approval
 "Dr Reddy's forms strategic tie up with Amgen")
Cipla to launch respiratory inhaler Synchrobreathe for asthma
Synchrobreathe, a breath-actuated inhaler (BAI) with a dose counter, helps in the management of Obstructive Airway Disease (OAD)
 "Cipla to launch respiratory inhaler Synchrobreathe for asthma")
Mallinckrodt Pharma acquires Therakos for $1.3 bn from Gores Group
Acquisition will add depth to Mallinckrodt's specialty brands segment, further diversifying its portfolio with an innovative high-value, high-margin drug/device system used in hospitals
 "Mallinckrodt Pharma acquires Therakos for $1.3 bn from Gores Group")
Denki Group to buy German bio-pharma firm Icon Genetics
With this acquisition, Denka Group will be able to develop norovirus vaccine and other vaccines which have never been produced by the Group
Corbion and MedinCell form JV to supply bio-based polymers for controlled release drugs
The joint venture, CM Biomaterials, will sell the PEG & PLA co-polymers to MedinCell partners who license the MedinCell controlled release technology, BEPO
 "Corbion and MedinCell form JV to supply bio-based polymers for controlled release drugs")
Global pharmaceutical packaging market to exceed $ 100 bn in 2019
India and China will be the fastest growing markets due to expanding pharma manufacturing capabilities and adoption of more stringent regulations, says a new Freedonia report
 "Global pharmaceutical packaging market to exceed $ 100 bn in 2019")
IDPL modernises tablet making unit at Gurgaon plant
Post-modernisation, IDPL's Gurgaon plant will be able to launch new products for lifestyle diseases such as diabetes, oncology, nephrology, cardiology, etc at affordable prices
 "IDPL modernises tablet making unit at Gurgaon plant")
Spisys ropes in Core Compounds to market products in North America
As per the pact, Core Compounds will market Spisys Ltd's oleoresins, essential oils and nutraceutical products in North America
SRF plans Rs 394 cr expansion for packaging and refrigerant biz
While it will set up a packaging film plant with an investment of Rs 356 cr, SRF will spend Rs 26 cr and Rs 12 on a pharma grade propellant plant and modification of refrigerant facility, respectively
 "SRF plans Rs 394 cr expansion for packaging and refrigerant biz")
Camlin Fine Sciences to set up a JV in US
The company will manufacture and trade antioxidants, food ingredients, blends, formulations etc in US and Canadian markets through this venture
Berry Plastics acquires Avintiv from PE firm Blackstone for $2.45 bn
Complementary products of Avintiv will enhance Berry Plastics' ability to capitalise on the rapidly growing global markets for hygiene and healthcare
 "Berry Plastics acquires Avintiv from PE firm Blackstone for $2.45 bn")
India clinical research market: Rebounding from post-2011 slump
Clinical research market, once a blue-eyed industry within healthcare sector, has been witnessing a slide since 2011. However, things are looking bright since last year
Ajanta Pharma receives US FDA nod for 3 ANDAs
The company has received the final approval from US FDA for montelukast tablets, sodium chewable tablets and oral granules
Sanofi to invest $2.17 bn in research collaboration with Regeneron
Two companies agree to jointly advance PD-1 (a programmed cell death protein 1 inhibitor) and other new immuno-oncology antibodies
 "Sanofi to invest $2.17 bn in research collaboration with Regeneron")
Robotics helps Apollo Hospital transform lives of 65 children
Even though robotic procedures offer many benefits, the expertise, infrastructure and referrals by many doctors is minimal hindering the growth of robotic surgeries in Chennai
 "Robotics helps Apollo Hospital transform lives of 65 children")
Hikma Pharma buys Roxane Labs from Boehringer Ingelheim in a $2.65-bn deal
The acquisition of specialty generics company Roxane will establish Hikma as the sixth largest company (by revenue) in the US generics market
 "Hikma Pharma buys Roxane Labs from Boehringer Ingelheim in a $2.65-bn deal")
GSK to set up Rs 1000-cr pharma plant in Bengaluru
GSK to set up Rs 1000-cr pharma plant in Bengaluru The greenfield facility, which will have an installed capacity of over 9 billion tablets and capsules per year, is expected to be operational by 2017
 "GSK to set up Rs 1000-cr pharma plant in Bengaluru")